News

Penta at AIDS 2026 and the International Workshop on Pediatrics & HIV

09 Jul, 2026

We’re pleased to share that a large delegation of Penta experts is heading to Rio de Janeiro, Brazil at the end of the month, taking part in three major events…
Read More

Strengthening routine electronic health data to improve care for advanced HIV disease in children and adolescents in Uganda: UP ART-THRIVE study

02 Jul, 2026

Uganda continues to face a high HIV burden among children and adolescents, with an estimated 71,000 young people aged under 15 years living with HIV and 3,100 AIDS-related deaths in…
Read More

Penta joins international Phase 2 study of zelicapavir for the treatment of RSV in children

30 Jun, 2026

Fondazione Penta is pleased to be part of a new international clinical development programme led by Enanta Pharmaceuticals, a clinical-stage biotechnology company, to advance zelicapavir, a new oral antiviral in…
Read More

Antimicrobial resistance and children living with HIV: An overlooked threat

26 Jun, 2026

About the author My name is José Sumbana, a young African investigator and Postdoctoral Fellow with a background in Microbiology, Biotechnology, and Life Sciences.
Read More

Could an antiviral used for COVID-19 also help babies fight RSV? Early THAI-CARES RSV study results offer a first answer

25 Jun, 2026

Every winter, hospitals around the world fill with infants struggling to breathe because of respiratory syncytial virus (RSV). Estimates show that RSV infects nearly every child by the time they…
Read More

NeoSep1, a landmark clinical trial to transform treatment options for newborns with sepsis, expands to Asia

24 Jun, 2026

Geneva, 24 June 2026 – An innovative international clinical trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, one of several Asian countries participating in…
Read More

Penta’s 2025 Annual Report has been published – explore it now!

17 Jun, 2026

We are pleased to share that Penta’s 2025 Annual Report is now available on our website. For more than thirty years, Penta has worked to ensure that pregnant people,
Read More

Empowerment, inspiration, and adaptation: My time at the Annual CHIVA Conference

13 Apr, 2026

This article was written by Penta Young Reporter, Arlene. Find out more about the Penta Young Reporters here. What is CHIVA?
Read More

Young people living with HIV should take their HIV medicines daily, according to the BREATHER+ trial

09 Apr, 2026

This article was originally published in the UCL Innovative Clinical Trials Unit website. Penta contributed to BREATHER+ by coordinating youth involvement through its Youth Trial Boards.
Read More

ENABLE project launches to evaluate enhancement of treatment of HIV in infants by adding monoclonal antibodies

27 Mar, 2026

Funded by Global Health EDCTP3 and the European Union, the project brings together 21 partners across Africa, Europe and the United States to improve early HIV treatment outcomes in infants.
Read More

How can we end TB in children if we can’t find it?

24 Mar, 2026

When we think of Tuberculosis (TB), we often picture an adult with a persistent cough. But there is another side that is often left in the shadows, the children who…
Read More

The impact of Penta’s Youth Trial Boards

20 Mar, 2026

Involving young people in clinical research might feel like a leap into the unknown for many researchers, but Penta’s experience shows that it is one of the most rewarding ways…
Read More

International Women’s Day – Women in STEM

08 Mar, 2026

Women in STEM : the future catalysts for change STEM is ever changing. It is vast, innovative, and transformative. It pioneers the very way in which people live,
Read More

Exclusion is a risk: rethinking how to protect pregnant individuals in research 

03 Mar, 2026

Written by Anna Maria Azzini, Stefania Vitali, Evelina Tacconelli, Catherine Fleming, Domenico Benvenuto and Federica Scanavini The historical tragedies linked to the use of medications during pregnancy that caused harm…
Read More

Results from the D3/Penta 21 trial signal a new chapter for childhood HIV care 

02 Mar, 2026

For the approximately 2.4 million children and adolescents living with HIV today, managing health is a lifelong commitment that has traditionally relied on a daily three-drug regimen. While adults have…
Read More

Penta joins BE READY, putting children and pregnant people at the heart of Europe’s pandemic preparedness

25 Feb, 2026

Emerging and re-emerging infectious diseases, from mpox and avian influenza to Ebola and chikungunya, continue to threaten global health with the potential to trigger large-scale epidemics or pandemics. Recent outbreaks…
Read More

Penta announces 2026 Brighter Future Award winners, honouring global champions of infectious disease equity

20 Feb, 2026

Padova, Italy – February 20, 2026 – In observance of the World Day of Social Justice, Penta Foundation ETS is proud to announce the recipients of the 
Read More

Right-sizing antibiotic treatment, highlights from the PediSEP-1 kick-off meeting 

29 Jan, 2026

From January 19–20, 2026, the PediSEP-1 consortium gathered in Mombasa, Kenya, for the official launch the project, designed to move paediatric care away from a “one-size-fits-all” approach and toward a…
Read More
1 2 3 22